Author: Salinas-Botrán, A.; Sanz-Cánovas, J.; Pérez-Somarriba, J.; Pérez-Belmonte, L.M.; Cobos-Palacios, L.; Rubio-Rivas, M.; de-CossÃo-Tejido, S.; Ramos-Rincón, J.M.; Méndez-Bailón, M.; Gómez-Huelgas, R.
Title: Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain() Cord-id: x764rxb9 Document date: 2021_10_8
ID: x764rxb9
Snippet: BACKGROUND: There are few studies on patients with heart failure (HF) hospitalized for COVID-19. Our aim is to describe the clinical characteristics of patients with HF hospitalized for COVID-19 and identify risk factors for in-hospital mortality upon admission. METHODS: We conducted a retrospective, multicenter study in patients with HF hospitalized for COVID-19 in 150 Spanish hospitals (SEMI-COVID-19 Registry). A multivariate logistic regression analysis was performed to identify admission fac
Document: BACKGROUND: There are few studies on patients with heart failure (HF) hospitalized for COVID-19. Our aim is to describe the clinical characteristics of patients with HF hospitalized for COVID-19 and identify risk factors for in-hospital mortality upon admission. METHODS: We conducted a retrospective, multicenter study in patients with HF hospitalized for COVID-19 in 150 Spanish hospitals (SEMI-COVID-19 Registry). A multivariate logistic regression analysis was performed to identify admission factors associated with in-hospital mortality. RESULTS: A total of 1718 patients were analyzed (56.5% men; median age 81.4 years). The overall case fatality rate was 47.6% (n = 819). The independent risk factors at admission for in-hospital mortality were: age (adjusted odds ratio [AOR]: 1.03; 95% confidence interval [95%CI]: 1.02–1.05; p < .001); severe dependence (AOR: 1.62; 95%CI: 1.19–2.20; p = .002); tachycardia (AOR: 1.01; 95%CI: 1.00–1.01; p = .004); and high C-reactive protein (AOR: 1.004; 95%CI:1.002−1.004; p < .001), LDH (AOR: 1.001; 95%CI: 1.001−1.002; p < .001), and serum creatinine levels (AOR: 1.35; 95%CI: 1.18−1.54; p < .001). CONCLUSIONS: Patients with HF hospitalized for COVID-19 have a high in-hospital mortality rate. Some simple clinical and laboratory tests can help to identify patients with a worse prognosis.
Search related documents:
Co phrase search for related documents- absolute value and acute myocardial infarction: 1
- absolute value and admission time: 1, 2, 3
- absolute value and logistic regression analysis: 1, 2, 3, 4
- absolute value and lung disease: 1, 2
- acute ards respiratory distress syndrome and adjusted odd ratio: 1
- acute ards respiratory distress syndrome and admission collect: 1
- acute ards respiratory distress syndrome and admission complication: 1, 2, 3
- acute ards respiratory distress syndrome and admission identify: 1
- acute ards respiratory distress syndrome and admission prior: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
- acute ards respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute ards respiratory distress syndrome and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- acute ards respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute ards respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute ards respiratory distress syndrome and low number: 1
- acute ards respiratory distress syndrome and low oxygen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute ards respiratory distress syndrome and low oxygen saturation: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
Co phrase search for related documents, hyperlinks ordered by date